Stryker Corporation

New York Stock Exchange
Back to all articles
Bearish -50

Earnings Miss: Stryker Corporation Missed EPS By 15% And Analysts Are Revising Their Forecasts

📉 Stryker Corporation (NYSE:SYK) reported first-quarter earnings with EPS of US$1.93, missing analyst forecasts by 15%.

💰 Revenue came in marginally short of estimates at US$6.0 billion despite the significant miss in profitability.

🔮 Analysts now forecast a 46% surge in statutory EPS to US$12.74 for 2026, up from previous estimates of US$12.16.

📈 Consensus revenue expectations for 2026 stand at US$27.3 billion, reflecting a 7.9% improvement over the last 12 months.

🧊 The annualized revenue growth rate is forecast to reach 11% through 2026, outpacing the industry average of 8.0%.

📉 The average price target for Stryker fell by 7.1% to US$389 following the disappointing quarterly results.

📊 Analysts show a divergence in views with optimistic targets reaching US$465 and pessimistic ones as low as US$315.

🤖 Long-term earnings power is considered more critical than next year's profits for investors evaluating the stock.

⚠️ A single warning sign has been identified by analysts that warrants attention before forming investment conclusions.

🧾 This analysis is based on historical data and forecasts from Simply Wall St without constituting financial advice.

Bullish Signals
  • Analysts have upgraded their earnings per share (EPS) estimates, reflecting a clear increase in optimism toward Stryker Corporation following the latest results.
  • The consensus forecast projects statutory EPS to soar 46% year-over-year, reaching US$12.74 per share by 2026.
  • Revenue forecasts indicate an annualized growth rate of 11%, which is substantially higher than the industry average forecast of 8.0% over the same period.
  • Long-term revenue outlook shows a satisfactory 7.9% improvement compared to the last 12 months, with consensus forecasts for US$27.3b in 2026.
  • Analysts have reconfirmed their revenue numbers, suggesting the company is tracking well against high-level expectations.
Risk Factors
  • Stryker Corporation missed its earnings per share (EPS) forecast by 15%, recording just US$1.93 per share, which signals immediate performance weakness.
  • Despite the optimistic long-term analyst revenue and EPS forecasts, the average price target has fallen 7.1% to US$389, indicating growing pessimism about the stock's current intrinsic value.
  • Analysts have widened their price target range significantly, with targets ranging from a high of US$465 to a low of US$315, reflecting substantial disagreement and uncertainty about the stock's fair value.
  • The article explicitly flags one warning sign for Stryker, suggesting there are hidden risks or fundamental issues that investors should be aware of before being too enthusiastic about the earnings beat on forecasts.
Full Analysis
Stryker Corporation (NYSE:SYK) reported disappointing first-quarter financial results, with statutory earnings per share missing analyst forecasts by 15% at US$1.93 per share. Revenue came in marginally below expectations at US$6.0 billion, signaling a tougher period for the medical technology firm as the market reassesses its outlook following this underperformance. Despite the near-term miss, 26 analysts maintain a consensus forecast projecting Stryker revenues to reach US$27.3 billion in 2026, representing a satisfactory 7.9% growth compared to the previous 12 months. Analyst expectations for future earnings have been revised upward significantly, with estimated statutory EPS predicted to soar 46% to US$12.74, up from the pre-report estimate of US$12.16 per share, indicating growing long-term optimism despite current earnings weakness. The average analyst price target decreased by 7.1% to US$389 following the report, suggesting concerns about the stock's intrinsic value that outweighed the improved earnings outlook. However, the growth trajectory remains robust; revenue is forecast to grow at an annualised rate of 11% through 2026, which aligns with the company's historical 9.9% five-year growth and substantially outpaces the industry average forecast of 8.0% per year for similar companies.